Tocilizumab Package Insert

Package Insert - YESCARTA
Tocilizumab or tocilizumab and corticosteroids (2.2, 2.3, 5.1). Neurologic toxicities, including fatal or life -threatening reactions, occurred in patients receiving YESCARTA, including concurrently ... Retrieve Doc

Durvalumab - Wikipedia
Durvalumab is an FDA-approved immunotherapy for cancer, developed by Medimmune/AstraZeneca. It is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 (PD-L1) with the PD-1 and CD80 (B7.1) molecules. ... Read Article

Effective Date: 02/08/2018 Ugus2012 Actemra (tocilizumab)
This policy and any information contained herein is the property of Blue Cross Blue Shield of Michigan and its subsidiaries, is strictly confidential, and its use is intended for the P&T committee, its members and BCBSM employees for the purpose of coverage determinations. ... Fetch Doc

Pharmacy Medical Necessity Guidelines: Actemra (tocilizumab)
1. Actemra (tocilizumab) [package insert]. South San Francisco, CA: Genentech, Inc.; September 2018. 2. American College of Rheumatology 2008 Recommendations for the use of nonbiologics and biologics disease-modifying antirheumatic drugs in rheumatoid arthritis. ... Return Document

ACTEMRA Can Be Used Alone Following Discontinuation Of ...
ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist indicated for treatment of: Rheumatoid Arthritis (RA) (1.1) • Adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more Disease- ... Access Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION Total CAR- These ...
Ensure tocilizumab and emergency equipment are available prior to infusion and during the recovery period. 2. Premedicate patient with acetaminophen and diphenhydramine or another H1-antihistamine ... Return Document

ACTEMRA (tocilizumab) - Caremark
ACTEMRA (tocilizumab) Actemra FEP Clinical Rationale RATIONALE FOR INCLUSION IN PA PROGRAM Background Actemra is an agent in the class of drugs known as biologic disease modifiers. It is used to treat ... Get Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION These Highlights Do Not ...
CIMZIA is provided in a package that contains everything required to reconstitute and inject the drug [see How Supplied/Storage and Handling (16) ... Read Content

Entyvio VMB245 R2 FULL PRESCRIBING INFORMATION CLEAN 08feb2018
2. Insert the syringe needle into the vial through the center of the stopper and direct the stream of Sterile Water for Injection to the glass wall of the vial to avoid excessive foaming. 3. Gently swirl the vial for at least 15 seconds to dissolve the lyophilized powder. Do not vigorously shake or invert. 4. ... Document Viewer

International Non-proprietary Name: tocilizumab Procedure No ...
Tocilizumab (RoActemra) is a recombinant humanized anti-human monoclonal antibody of the immunoglobulin G1 (IgG1) sub-class directed against the soluble and membrane-bound interleukin 6 receptor (sIL-6R and mIL-6R). ... Fetch Full Source

Injection: 150 Mg/mL Solution In A Single-use Sensoready Pen ...
H) The COSENTYX reco nstituted solution contains 150 mg of secukinumab in 1 mL of solution. After reconstitution, use the solution immediately or store in the refrigerator at 2ºC to 8ºC (36ºF to 46ºF) for up to 24 hours. ... Read Document

HIGHLIGHTS OF PRESCRIBING INFORMATION Uveitis (UV) (1.10 ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for ... Fetch This Document

HIGHLIGHTS OF PRESCRIBING INFORMATION ...
3 • The recommended initial doseis 400mg/m2administered as a 120-minute intravenous infusion. • The recommended subsequent dosage (all other infusions) is 250mg/m2weekly as a60-minuteinfusionuntil disease progression or unacceptable toxicity. ... Get Doc

Reference ID: 3393637 - Food And Drug Administration
(tocilizumab) is indicated for the treatment of active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. 1.3 Systemic Juvenile Idiopathic Arthritis (SJIA) ACTEMRA ® (tocilizumab) is indicated for the treatment of active systemic juvenile idiopathic arthritis in patients 2 years of age and older. ... Fetch Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION ACTEMRA. Dose ...
HIGHLIGHTS OF PRESCRIBING INFORMATION . These highlights do not include all the information needed to use ACTEMRA safely and effectively. See full prescribing information for ACTEMRA. Dose Modifications. ACTEMRA ® (tocilizumab) Injection, for intravenous infusion . ... View Full Source

Pharmacy Medical Necessity Guidelines: Actemra (tocilizumab)
5 Pharmacy Medical Necessity Guidelines: Actemra® (tocilizumab) of rheumatoid arthritis requires trial and failure of treatment with, contraindication to or clinical inappropriateness of treatment with Remicade or Simponi Aria. Added exception language for Members new to the plan and stable on Actemra (tocilizumab) prior to enrollment. 11. ... Fetch Full Source

For Injection, USP - HemOnc.org
Package Insert Thiotepa for Injection, USP DESCRIPTION Thiotepa for injection is an ethylenimine-type compound. It is supplied as a non-pyrogenic, sterile lyophilized powder for intravenous, intracavitary or intravesical administration, containing 15 mg and 30 mg of thiotepa. Thiotepa is a synthetic product with antitumor activity. ... Get Doc

Actemra® (tocilizumab) (IV And SC) - Magellan Provider
Tocilizumab (Actemra) is a humanized interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody that is approved to reduce the signs and symptoms of moderate to severe rheumatoid arthritis in adults who have had ... Get Document

HYCAMTIN IV Prescribing Information - HemOnc.org
6 months after completion of, a platinum-containing regimen. One complete and 6 partial responses were seen in 60 patients, for a response rate of 12%. ... Retrieve Here

Actemra (tocilizumab) - Wellmark.com
Actemra (tocilizumab) BENEFIT APPLICATION . Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations or exceptions may apply. Benefits may vary based on contract, and individual member benefits must be verified. ... Read More